Saxty Gordon, Woodhead Steven J, Berdini Valerio, Davies Thomas G, Verdonk Marcel L, Wyatt Paul G, Boyle Robert G, Barford David, Downham Robert, Garrett Michelle D, Carr Robin A
J Med Chem. 2007 May 17;50(10):2293-6. doi: 10.1021/jm070091b. Epub 2007 Apr 24.
Using fragment-based screening techniques, 5-methyl-4-phenyl-1H-pyrazole (IC50 80 microM) was identified as a novel, low molecular weight inhibitor of protein kinase B (PKB). Herein we describe the rapid elaboration of highly potent and ligand efficient analogues using a fragment growing approach. Iterative structure-based design was supported by protein-ligand structure determinations using a PKA-PKB "chimera" and a final protein-ligand structure of a lead compound in PKBbeta itself.
利用基于片段的筛选技术,5-甲基-4-苯基-1H-吡唑(IC50为80微摩尔)被鉴定为蛋白激酶B(PKB)的一种新型低分子量抑制剂。在此,我们描述了使用片段生长方法快速构建高效且配体高效的类似物。基于结构的迭代设计得到了使用PKA-PKB“嵌合体”进行的蛋白质-配体结构测定以及PKBβ自身中一种先导化合物的最终蛋白质-配体结构的支持。